Latest Breaking News On - Tscan therapeutics company profile - Page 1 : comparemela.com

Needham & Company LLC Reaffirms Buy Rating for TScan Therapeutics (NASDAQ:TCRX)

Needham & Company LLC reiterated their buy rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a report issued on Monday, MarketBeat Ratings reports. They currently have a $11.00 price target on the stock. TCRX has been the topic of a number of other reports. Wedbush reissued an outperform rating and issued a […]

United statesTscan therapeutics company profileCannon global investment managementLetko brosseau associates incNeedham companyTscan therapeutics incFree reportMarketbeat ratingsTherapeutics trading downGet free reportFire capitalGlobal investment managementTherapeutics companyTherapeutics daily

TScan Therapeutics (NASDAQ:TCRX) Given Outperform Rating at Wedbush

Wedbush restated their outperform rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note published on Wednesday morning, RTT News reports. The firm currently has a $10.00 target price on the stock. Wedbush also issued estimates for TScan Therapeutics’ Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.23) EPS, […]

United statesTscan therapeutics company profileRenaissance technologiesTscan therapeutics incBlackrock incFree reportTherapeutics stockGet free reportJane street groupTherapeutics companyTherapeutics dailyTscan therapeuticsNasdaq tcrxReiterated rating

Pale Fire Capital SE Acquires Shares of 16,575 TScan Therapeutics, Inc (NASDAQ:TCRX)

Pale Fire Capital SE Acquires Shares of 16,575 TScan Therapeutics, Inc (NASDAQ:TCRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Barbara klenckeTimothyj barberichHoldings channelStifel financial corpTscan therapeutics company profileRenaissance technologiesLetko brosseau associates incTscan therapeutics incSecurities exchange commissionPale fire capitalFree reportFinancial corpStreet corpDirector timothyExchange commissionDirector barbara klencke

Pale Fire Capital SE Makes New Investment in TScan Therapeutics, Inc (NASDAQ:TCRX)

Pale Fire Capital SE Makes New Investment in TScan Therapeutics, Inc (NASDAQ:TCRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Timothyj barberichBarbara klenckeMillennium managementExchange commissionTscan therapeutics company profileRenaissance technologiesSecurities exchange commissionTscan therapeutics incPale fire capitalFree reportStreet groupState street corpStreet corpDirector timothyDirector barbara klenckeTherapeutics stock

Lifesci Capital Reiterates Outperform Rating for TScan Therapeutics (NASDAQ:TCRX)

Lifesci Capital Reiterates Outperform Rating for TScan Therapeutics (NASDAQ:TCRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Monashee investment managementAsset management incTscan therapeutics incTscan therapeutics company profileStifel financial corpPrivium fund managementGet free reportLifesci capitalAsset managementInvestment managementFinancial corpState street corpStreet corpTherapeutics companyTherapeutics daily